Arno Therapeutics, Inc 4
4 · Arno Therapeutics, Inc · Filed Nov 6, 2013
Insider Transaction Report
Form 4
Reizman Yacov
Director
Transactions
- Award
Stock Option (right to buy)
2013-11-04+68,448→ 68,448 totalExercise: $2.40Exp: 2023-11-04→ Common Stock (68,448 underlying)
Holdings
- 38,287(indirect: By FCC Ltd.)
Warrants (right to buy)
Exercise: $8.80From: 2010-09-09Exp: 2015-09-09→ Common Stock (38,287 underlying) - 38,285(indirect: By FCC Ltd.)
Common Stock
- 3,750
Stock Option (right to buy)
Exercise: $8.00Exp: 2020-11-05→ Common Stock (3,750 underlying) - 15,750(indirect: By FCC Ltd.)
2010 Class B Warrants
Exercise: $3.08From: 2010-09-09Exp: 2015-09-09→ Common Stock (15,750 underlying)
Footnotes (3)
- [F1]The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- [F2]Vests in three equal annual installments commencing 11/5/11.
- [F3]Vests in equal 36-monthly installments commencing 12/4/13.